Varicella-zoster virus (VZV) is a species-specific herpesvirus which infects sensory ganglia. We have developed a model of infection of human intact explant dorsal root ganglia (DRG).Varicella-zoster virus (VZV) is the etiological agent for varicella (chicken pox) and herpes zoster (shingles) (1, 3). During primary VZV infection, VZV accesses nerve axons to reach sensory ganglia, where it establishes latency (4,5,7,14,15,16,19). Reactivation from latency results in new infectious virus and axonal transport of VZV to the skin to cause herpes zoster. During herpes zoster, neural and dermoepidermal inflammations occur, resulting in neuropathic pain and the typical dermatomal rash (8). The complex aberrant repair processes that occur during herpes zoster can result in chronic neuropathic pain (postherpetic neuralgia), which can last for years after resolution of the rash (26).The high species specificity of VZV has complicated the development of small animal models that mimic productive infection (1, 17), although advances in tissue culture techniques enabled the development of SCID-hu mouse models utilizing grafted human tissue (17,18,20,21). Grafting of neural cells has been used to examine infection of neurons and glial cells (2). In a variation of this model, intact human fetal dorsal root ganglia (DRG) have been grafted into SCID-hu mice to show that after initial productive infection, VZV persisted in a form consistent with the establishment of latency (29).We have previously shown that single-cell preparations of neurons from dissociated human DRG support virus replication and that unlike productive infection of human fibroblasts (HFs), infected neurons are resistant to apoptosis (13). We also provided evidence that the VZV ORF63 gene product confers resistance to apoptosis during neuronal infection (12).